Quantcast

Latest Systemic lupus erythematosus Stories

2014-10-15 12:27:27

A Substantial Need Remains for Emerging SLE Biologics That Can Prevent Acute Flares and That Treat Severe Manifestations, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 15, 2014 /PRNewswire/ -- Decision Resources Group finds that although use of biologics in SLE has increased in the past three years, largely due to uptake of GlaxoSmithKline's Benlysta, overall physician-reported patient share of biologics remains modest. Less than half of SLE patients considered...

2014-10-09 00:20:40

Empire State Building Glows Purple to Celebrate Lupus Foundation of America's National Gala and to Call Attention to Need for Increased Awareness and Investment in Lupus Research NEW YORK, Oct. 8, 2014 /PRNewswire-USNewswire/ -- On Wednesday, October 8, patients, caregivers, researchers, celebrities and supporters gathered at Gotham Hall in New York City for the Lupus Foundation of America's Evening of Hope National Gala. The event raised critical funds needed to support the...

2014-10-06 16:27:08

NORWALK, Conn., Oct. 6, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network, a leading online community for rheumatologists, features major coverage of new advances against lupus, which is the focus of Lupus Awareness Month in October. Lupus, which affects at least 300,000 Americans, is an autoimmune disease in which the body's immune system attacks its own tissues and organs, including the skin, the kidneys, and the brain. Last week the US National Institutes of Health...

2014-10-02 12:31:37

WASHINGTON, Oct. 2, 2014 /PRNewswire-USNewswire/ -- Sandra C. Raymond, President & CEO of the Lupus Foundation of America issued the following statement in response to Eli Lilly and Company's announcement of the results of two Phase III clinical trials of tabalumab, a biologic agent studied for the treatment of lupus. Unfortunately, the trials did not show favorable results and the company is terminating these studies. The halting of the studies was not based on safety concerns....

2014-10-02 08:29:46

INDIANAPOLIS, Oct. 2, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today it will discontinue development of tabalumab­ -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns. ­­­­ In the ILLUMINATE 1 study, tabalumab did not achieve the primary endpoint, at either dose studied, of statistically significant...

2014-10-01 16:27:14

HAYWARD, Calif., Oct. 1, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today confirmed it is engaged in potential partnership negotiations for blisibimod for both lupus and IgA nephropathy in territories outside the United States. Anthera does not intend to communicate further regarding these discussions unless and until a definitive agreement is executed. There can be no assurance that such a definitive agreement will be executed relating to any proposed...

2014-09-30 12:29:58

WASHINGTON, Sept. 30, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, announced four grants that will allow lupus investigators to continue critical lupus research. An additional grant has been awarded to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis. http://photos.prnewswire.com/prnvar/20121113/DC11393LOGO The Lupus Foundation of...

2014-09-26 08:25:39

Comedian Jo Koy will serve as Walk Ambassador for San Francisco's Walk to End Lupus Now on October 26th WASHINGTON, Sept. 26, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will host its annual Walk To End Lupus Now(TM )event in San Francisco on Sunday, October 26, 2014 at Golden Gate Park. Walk Ambassador, comedian Jo Koy, will join thousands of San Francisco residents to raise money for lupus research and education programs, increase awareness of the disease, and...

2014-09-22 12:26:11

More than $300,000 raised to support research, education and support services for people affected by lupus LOS ANGELES, Sept. 22, 2014 /PRNewswire-USNewswire/ -- Hollywood stars of television turned out to shed light on the cruel mystery that is lupus and raise critically needed funds for research and education programs during the Lupus Foundation of America's (LFA) Walk to End Lupus Now(TM), in Los Angeles on Saturday, September 20, 2014. Walk to End Lupus Now Grand Marshal,...

2014-09-15 12:27:50

Hundreds Step Up For New Lupus Treatments NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Over 200 patients, families, physicians and scientists came together under one roof Saturday to learn, interact and participate in the drive for better lupus treatments at New York City's first Lupus Trials Fair launched by the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation. Attendees interacted directly with researchers at eight of NYC's leading institutions -- sharing experiences,...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.